GlassScriptPhysician profile
Jeffrey M King
NPI 1992795116
$4,525.92
in general payments reported to CMS, 2019-2025
9 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $358 · 2021: $452 · 2022: $249 · 2023: $1,821 · 2024: $813 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,564 · Food and Beverage: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,564.48 |
| Food and Beverage | $1,378.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,007.46 | 2023-2024 | Coblation, Tula |
| Acclarent, INC | $698.08 | 2019-2023 | Trudi Nav Cable |
| Integra Lifesciences Corporation | $437.44 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Aerin Medical INC. | $415.63 | 2020-2023 | |
| Intersect Ent, INC. | $388.98 | 2019-2022 | |
| Baxter Healthcare | $212.28 | 2022-2024 | Floseal |
| Neurent Medical Limited | $142.63 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Mallinckrodt Enterprises LLC | $114.75 | 2019 | |
| Medical Device Business Services, INC. | $108.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.